Baricitinib could delay progression of type 1 diabetes, a groundbreaking potential treatment for this devastating autoimmune disease. This research explores the intricate mechanisms behind baricitinib’s possible impact on immune responses, beta-cell function, and ultimately, the progression of type 1 diabetes. Early studies hint at promising results, but further investigation is crucial to fully understand the…
